Insulin Toujeo® — A Novel Basal Long-Acting Insulin Formulation. Part 2. Clinical Efficacy and Safety

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
doi 10.22141/2224-0721.8.72.2015.72337
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Publishing House Zaslavsky

Related search

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-Long-Acting Basal Insulin

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2012English

Pharmacological and Clinical Profiles of New Soluble Basal Insulin Analogue, Insulin Detemir (Levemir®)

Folia Pharmacologica Japonica
Pharmacology
2008English

Long Acting Insulin Glargine Overdose, a Surprising Long Lifetime

Toxicology Communications
2019English

Systematic Review and Economic Evaluation of a Long-Acting Insulin Analogue, Insulin Glargine

Health Technology Assessment
MedicineHealth Policy
2004English

Fiasp: A New Faster-Acting Insulin Aspart Formulation for Diabetes

Prescriber
Pharmacology
2017English

Efficacy and Safety of Inhaled Insulin Therapy

Annals of Internal Medicine
Internal MedicineMedicine
2006English

Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Abediterol (LAS100977), a Novel Long-Acting Β2-Agonist: Efficacy, Safety and Tolerability in Persistent Asthma

Respiratory Medicine
PulmonaryRespiratory Medicine
2014English

Long-Acting Insulin: Slow Release of Insulin From a Biodegradable Matrix Implanted in Diabetic Rats

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy